Hi JD
There are many companies following the virotherapy and CPI route. Have a look at Targovax CPI resistant melanoma results from last year (from memory 35% response rate treating failed cpi treated cases)
If you want more science have a look at this paper
https://www.cell.com/molecular-therapy-family/oncolytics/fulltext/S2372-7705(21)00024-3
specifically look at the response rate figure from the same model (B-16) that Race has used and compare the results. You will see there is complete inhibition of tumor growth and the activation of a systemic abscopal effect.
There are many other examples.
Ann: Zantrene Improves Immune Therapy Treatment of Melanoma, page-66
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.055(3.31%) |
Mkt cap ! $273.4M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.68 | $1.61 | $271.5K | 166.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1996 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 1305 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |